-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
BioNexus Gene Lab Corp quarterly/annual Depreciation history and growth rate from 2018 to 2024.
- BioNexus Gene Lab Corp Depreciation for the quarter ending March 31, 2025 was $26.6K, a 32.3% increase year-over-year.
- BioNexus Gene Lab Corp annual Depreciation for 2024 was $20.1K, a 75.8% decline from 2023.
- BioNexus Gene Lab Corp annual Depreciation for 2023 was $83.3K, a 8.94% decline from 2022.
- BioNexus Gene Lab Corp annual Depreciation for 2022 was $91.4K, a 0.16% increase from 2021.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)